Why Cardiovascular Systems Shares Are Trading Higher By 48%; Here Are 20 Stocks Moving Premarket

Gainers

• Wearable Devices Ltd. WLDS shares rose 65% to $1.03 in pre-market trading after the company received approval from Israel Innovation Authority for $900,000 grant to finance further development of company's manufacturing process for its Mudra Band.
• Hempacco Co., Inc. HPCO rose 56.4% to $1.1804 in pre-market trading after declining 6% on Wednesday.
• Cardiovascular Systems, Inc.. CSII rose 48.3% to $19.75 in pre-market trading following Q2 results.
• SeaStar Medical Holding Corporation ICU shares rose 40.7% to $6.76 in pre-market trading. SeaStar Medical received FDA approval to begin study with selective cytopheretic device to reduce hyperinflammation in adults with acute kidney injury.
• Genetic Technologies Limited GENE shares rose 27.4% to $1.86 in pre-market trading. Genetic Technologies announced new publication highlights geneType's ability to detect breast cancer earlier and provide data for risk stratification.
• AppLovin Corporation APP rose 27.4% to $16.16 in pre-market trading after the company issued strong Q1 guidance.
• Cryptyde, Inc. TYDE rose 21.1% to $0.2350 in pre-market trading. Cryptyde’s Forever 8 generated over $1 million of revenue in a single Day.
• Sonos, Inc. SONO rose 13.3% to $20.27 in pre-market trading after the company reported better-than-expected Q1 results.
• Organovo Holdings, Inc. ONVO rose 11.6% to $2.17 in pre-market trading after gaining 11% on Wednesday.
• FAT Brands Inc. FATBB rose 10.2% to $7.70 in pre-market trading.

Losers

• Tivic Health Systems, Inc. TIVC fell 51% to $0.2450 in pre-market trading after the company announced pricing of $5 million public offering of 20 million shares at a price of $0.25/share.
• Revelation Biosciences, Inc. REVB shares fell 30.2% to $3.74 in pre-market trading after dropping 19% on Wednesday. Revelation Biosciences recently announced biomarker data from a preclinical model of acute and chronic kidney disease, supporting the potential clinical utility of REVTx-300 previously announced in November last year.
• Vintage Wine Estates, Inc. VWE shares dropped 27.2% to $2.03 in pre-market trading after the company announced plans to restate Q1 financial statements. The company announced preliminary unaudited/unreviewed second quarter fiscal 2023 financial results.
• TechTarget, Inc. TTGT fell 25.4% to $36.80 in pre-market trading following Q4 results.
• Veru Inc. VERU fell 20.3% to $4.0885 in pre-market trading after reporting downbeat quarterly results.
• Digital Turbine, Inc. APPS fell 17.2% to $13.42 in pre-market after the company reported worse-than-expected Q3 results and issued weak FY23 guidance
• Affirm Holdings, Inc. AFRM fell 15.8% to $13.48 in pre-market trading after the company reported worse-than-expected Q2 results, issued weak guidance and announced a 19% workforce reduction.
• Purple Innovation, Inc. PRPL fell 15.8% to $4.75 in pre-market trading after the company priced its public offering of 13.4 million shares at a public offering price of $4.50 per share..
• Matrix Service Company MTRX fell 13.3% to $7.95 in pre-market trading as the company posted a wider Q2 loss.
• BYND Cannasoft Enterprises Inc. BCAN shares fell 11.6% to $2.50 in pre-market trading.

Now Read This: $12M Bet On Vera Therapeutics? Check Out These 3 Stocks Insiders Are Buying